These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6095856)

  • 1. Decreased adenosine cyclic 3',5'-monophosphate phosphodiesterase activity in rat brain following triethyltin intoxication.
    Macovschi O; Prigent AF; Nemoz G; Pageaux JF; Pacheco H
    Biochem Pharmacol; 1984 Nov; 33(22):3603-8. PubMed ID: 6095856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of an extract of Ginkgo biloba on the 3',5'-cyclic AMP phosphodiesterase activity of the brain of normal and triethyltin-intoxicated rats.
    Macovschi O; Prigent AF; Nemoz G; Pacheco H
    J Neurochem; 1987 Jul; 49(1):107-14. PubMed ID: 3035090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of ATPase activities of brain and liver homogenates by triethyltin (TET).
    Jacobs KS; Lemasters JJ; Reiter LW
    Dev Toxicol Environ Sci; 1983; 11():517-20. PubMed ID: 6234157
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification and characterization of both the cytosolic and particulate forms of cyclic GMP-stimulated cyclic AMP phosphodiesterase from rat liver.
    Pyne NJ; Cooper ME; Houslay MD
    Biochem J; 1986 Mar; 234(2):325-34. PubMed ID: 3013156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute in vivo stimulation of low-Km cyclic AMP phosphodiesterase activity by insulin in rat-liver Golgi fractions.
    Benelli C; Desbuquois B; De Gallé B
    Eur J Biochem; 1986 Apr; 156(1):211-20. PubMed ID: 3007144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Implication of lipid peroxidation in triethyltin poisoning in the rat].
    Boulieu R; Munoz JF; Macovschi O; Pacheco H
    C R Seances Soc Biol Fil; 1988; 182(2):196-201. PubMed ID: 2973827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of cell-free brain cyclic nucleotide phosphodiesterase activities to cyclic AMP decay in intact brain slices.
    Whalin ME; Garrett RL; Thompson WJ; Strada SJ
    Second Messengers Phosphoproteins; 1988-1989; 12(5-6):311-25. PubMed ID: 2856115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased methylation of chloroform extractable products and CTP: cholinephosphate cytidylyltransferase in brain membrane preparations from triethyltin-intoxicated rats.
    Mages F; Macovschi O; Prigent AF; Fonlupt P
    Pharmacol Toxicol; 1989 Oct; 65(4):302-5. PubMed ID: 2555805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification, characterization and regional distribution in brain of RPDE-6 (RNPDE4A5), a novel splice variant of the PDE4A cyclic AMP phosphodiesterase family.
    McPhee I; Pooley L; Lobban M; Bolger G; Houslay MD
    Biochem J; 1995 Sep; 310 ( Pt 3)(Pt 3):965-74. PubMed ID: 7575434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a liver low Michaelis-Menten constant 3',5'-cyclic adenosine monophosphate phosphodiesterase activity sensitive to thyroid status.
    Benelli C; Geoffroy V; Fouque F; Lopez S; Desbuquois B
    Endocrinology; 1991 May; 128(5):2376-86. PubMed ID: 1850351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification, characterization and production of rabbit antibodies to rat liver particulate, high-affinity, cyclic AMP phosphodiesterase.
    Whitson RH; Appleman MM
    Biochim Biophys Acta; 1982 Feb; 714(2):279-91. PubMed ID: 6275911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related changes of cyclic AMP phosphodiesterase activity in rat brain regions and a new phosphodiesterase inhibitor--nootropic agent adafenoxate.
    Stancheva SL; Alova LG
    Gen Pharmacol; 1991; 22(5):955-8. PubMed ID: 1662175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form.
    Lavan BE; Lakey T; Houslay MD
    Biochem Pharmacol; 1989 Nov; 38(22):4123-36. PubMed ID: 2480793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin stimulation of particulate, low Km adenosine 3',5'-monophosphate phosphodiesterase activity in fat cells of the obese-hyperglycemic (ob/ob) mouse.
    Malbon CC; Fain JN
    J Cyclic Nucleotide Res; 1977 Oct; 3(5):315-23. PubMed ID: 201679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic nucleotide phosphodiesterase from a particulate fraction of rat brain. Evidence for an activator deficient form.
    Lindl T; Chapman G
    Biochem Biophys Res Commun; 1976 Aug; 71(4):1273-82. PubMed ID: 9937
    [No Abstract]   [Full Text] [Related]  

  • 16. Distribution of cyclic AMP phosphodiesterase in adipose tissue from trained rats.
    Kenno KA; Durstine JL; Shepherd RE
    J Appl Physiol (1985); 1986 Oct; 61(4):1546-51. PubMed ID: 3023273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of human placental cytosolic adenosine 3',5'-monophosphate phosphodiesterase by inhibitors and insulin treatment.
    Xiong LM; LeBon TR; Fujita-Yamaguchi Y
    Endocrinology; 1990 Apr; 126(4):2102-9. PubMed ID: 2156681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissimilar cyclic nucleotide phosphodiesterase activities in subcellular fractions from normal and SV40-transformed WI-38 fibroblasts.
    Nemecek GM; Butcher RW
    J Cyclic Nucleotide Res; 1979 Dec; 5(6):449-61. PubMed ID: 94064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of transsynaptically elicited increase of 3':5'-cyclic AMP by endogenous phosphodiesterase activator.
    Gnegy ME; Costa E; Uzunov P
    Proc Natl Acad Sci U S A; 1976 Feb; 73(2):352-5. PubMed ID: 174103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of cyclic nucleotide phosphodiesterase activity in rhesus fetal muscle.
    Beatty CH; Herrington PT; Bocek RM
    Biol Neonate; 1977; 32(1-2):33-42. PubMed ID: 198031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.